Vericel Corporation Reports Strong Q3 2026 Results and Raises Full-Year Guidance
Vericel Corporation (VCEL) delivered robust third-quarter 2026 financial results, characterized by a 26% year-over-year increase in total revenue to $85.4 million. Growth was driven across all major commercial franchises, including a 21% rise in MACI revenue and a significant 52% surge in the Burn Care segment. The company also achieved record quarterly revenue for Epicel and saw substantial expansion in NexoBrid utilization. Following these strong results, Vericel raised its full-year revenue guidance to a range of $344 million to $346 million, up from previous estimates. Profitability metrics also improved, with Non-GAAP Adjusted EBITDA growing 48% year-over-year and an increased Adjusted EBITDA margin target for the full year. The company maintains a strong liquidity position with over $235 million in cash and investments.
Tickers: $VCEL
Topics: cash flow EBITDA net income revenue growth share buybacks